Gaudium IVF is engaged in providing assisted reproductive technology (ART) services in India, with a primary focus on in vitro fertilization (IVF) and related fertility treatments. The Company has expanded its presence across multiple states through a hub-and-spoke model designed to improve accessibility and patient outreach. Founded by its Promoter, Dr. Manika Khanna, who has received advanced training in gynecological endoscopic surgery from Kiel, Germany, and in gynaec endoscopy from Melbourne IVF Gujarat Private Limited, Gaudium IVF operates more than 30 locations comprising 7 hubs and 28 spokes. It has also entered into strategic alliances with infertility experts to promote awareness and expand access to ART services. The Company offers a comprehensive range of treatments including IVF, intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI) and ovulation induction, with protocols designed to address diverse male and female infertility challenges.
Price Band₹75 - ₹79 |
Dates20 Feb - 24 Feb |
GMP₹0 (0.00%) |
Subscriptions7.27 times |
Issue Size₹165.00 Crs |
20 Feb 26
24 Feb 26
25 Feb 26
25 Feb 26
26 Feb 26
27 Feb 26
Price Band₹75 - ₹79 |
Listing AtNSE & BSE |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹90.00 Cr (1.14 Cr Shares) |
Offer For Sale₹75.00 Cr (0.95 Cr Shares) |
Total Issue₹165.00 Cr (2.09 Cr Shares) |
Face Value₹5 per equity share |
| Investor Category | Lot | Shares | Amount | |
|---|---|---|---|---|
| Retail |
Minimum
1
189
14,931
Maximum
13
2,457
1,94,103
|
|||
| Small HNI |
Minimum
14
2,646
2,09,034
Maximum
66
12,474
9,85,446
|
|||
| Big HNI |
Minimum
67
12,663
10,00,377
|
|||
Updated as on 24-Feb-2026 19:00:00
| Investor Category | Subscription (times) | Shares Offered | Shared Bid |
|---|---|---|---|
| QIB | 1.62 | 41,77,240 | 67,85,478 |
| NII | 14.05 | 31,32,930 | 4,40,22,069 |
| bNII (bids above ₹10L) | 12.71 | 20,88,620 | 2,65,55,634 |
| sNII (bids between ₹2L to ₹10L) | 16.73 | 10,44,310 | 1,74,66,435 |
| Retail | 7.60 | 73,10,170 | 5,55,42,942 |
| Total | 7.27 | 1,46,20,340 | 10,63,50,489 |
The estimated Grey Market Premium of Gaudium IVF IPO is ₹0 per share (0.00%)
| Particulars | Allocation |
|---|---|
| QIBs | Not more than 50% of Net Offer |
| Big HNIs (NII) | Not less than 10% of Net Offer |
| Small HNIs (NII) | Not less than 5% of Net Offer |
| Retail | Not less than 35% of Net Offer |
| Particulars | Sep-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| Revenue | 494.99 | 707.24 | 478.90 | 442.37 |
| PAT | 125.06 | 191.27 | 103.17 | 135.25 |
| Net Worth | 588.55 | 462.97 | 269.86 | 227.30 |
| Borrowings | 225.14 | 189.34 | 157.25 | 97.81 |
| Assets | 1,066.19 | 885.13 | 510.07 | 366.27 |
| NAV (₹) | 9.59 | 7.54 | 4.40 | 3.70 |
| EPS (₹) | 2.04 | 3.12 | 1.68 | 2.20 |
The financial information presented is on a consolidated basis.
| KPI | VALUES |
|---|---|
| EBITDA | 40.48% |
| PAT | 26.96% |
| ROE | 41.31% |
| ROCE | 39.70% |
| Debt to Equity | 0.41 |
| PE Ratio | 25.32 |
| PB Ratio | 10.48 |
| Mkt Cap (in Crs.) | 575.02 |
| Particulars | Gaudium IVF | Progyny Inc. | Inspire IVF |
|---|---|---|---|
| Revenue | 707.24 | 99,941.20 | 262.97 |
| PAT | 191.27 | 4,652.42 | 55.11 |
| EPS (₹) | 3.12 | 50.52 | 0.17 |
| NAV (₹) | 7.54 | 394.20 | 4.34 |
| RONW | 41.71% | 12.90% | 3.97% |
| EBITDA | 40.48% | 6.05% | 36.61% |
| PAT Mrgn | 26.96% | 4.59% | 20.44% |
| PE Ratio | 25.32 | 41.56 | 11.43 |
| Debt to Equity | 0.41 | - | - |
All information pertains to FY 2024-25. The PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of December 31, 2024. for Peers
| Particulars | Gaudium IVF |
|---|---|
| Revenue | 707.24 |
| PAT | 191.27 |
| EPS (₹) | 3.12 |
| NAV (₹) | 7.54 |
| RONW | 41.71% |
| EBITDA | 40.48% |
| PAT Mrgn | 26.96% |
| PE Ratio | 25.32 |
| Debt to Equity | 0.41 |
| Progyny Inc. | Inspire IVF |
|---|---|
| 99,941.20 | 262.97 |
| 4,652.42 | 55.11 |
| 50.52 | 0.17 |
| 394.20 | 4.34 |
| 12.90% | 3.97% |
| 6.05% | 36.61% |
| 4.59% | 20.44% |
| 41.56 | 11.43 |
| - | - |
All information pertains to FY 2024-25. The PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of December 31, 2024. for Peers
| Name | Shareholding |
|---|---|
| Manika Khanna | 99.32% |
| Others | 0.66% |
| Total | 99.98% |
| Name | Designation |
|---|---|
| Manika Khanna | Chairman & MD |
| Rakesh Sharma | CFO |
Name: Gaudium IVF And Women Health Limited
Address: B1/51, Janak Puri, B-1, New Delhi – 110058, India
Number: 011- 4885 8585
Email: compliance@gaudiumivfcentre.com
Website: https://www.gaudiumivfcentre.com
Frequently Asked questions?
Find answers to common questions that come in your mind related to IPO.
Gaudium IVF IPO is a Mainboard IPO having an issue size of Rs. ₹165.00 Crs. Gaudium IVF IPO is priced at ₹75 - ₹79 per share. The issue opens on 20 Feb 26 and closes on 24 Feb 26.
Gaudium IVF IPO opens on 20 Feb 26 and closes on 24 Feb 26.
The estimated Grey Market Premium of Gaudium IVF IPO is ₹0 per share (0.00%).
The minimum lot size of Gaudium IVF IPO is 189 shares & the minimum application amount is Rs. 14931.
The allotment date of Gaudium IVF IPO is 25 Feb 26.
The listing date of Gaudium IVF IPO is 27 Feb 26.
Gaudium IVF IPO is subscribed 7.27 times.
Gaudium IVF IPO is priced at ₹75 - ₹79 per share.
Click the allotment link on Gaudium IVF IPO page of IPO360.